Serum and urine concentrations were measured after administration of 0.5-and 1-g doses of cefamandole intramuscularly and intravenously to healthy volunteers. Intramuscular doses of 0.5 and 1 g yielded serum concentrations at 1 h of 14.7 and 35.6 ,ug/ml, respectively. Significant antibacterial concentrations persisted through h 8. Intravenous doses of 0.5 and 1 g resulted in respective peak serum levels of 21 ,ug/ml at 45 min and 103 ,ug/ml at 15 min; these serum levels rapidly declined. Very high urine concentrations were achieved during the first 8 h after injection.boxylic acid, is a new cephalosporin derivative with a broad spectrum of antibacterial activity against a wide variety of gram-positive and gram-negative bacteria (3, 5a, 6, 10). Comparative in vitro studies with other presently available cephalosporin antibiotics showed cefamandole to be the most active against most Enterobacteriaceae and Haemophilus influenzae (3, 5a, 6, 10). The drug appears to be more resistant to the action of staphylococcal betalactamase than cefazolin and more resistant than cephalothin to beta-lactamases produced by some gram-negative bacteria (7, 11). We now report studies of the pharmacological behavior of this new antibiotic in normal human volunteers.
MATERIALS AND METHODSSerum and urine concentrations after parenteral administration of cefamandole were determined in 15 healthy volunteers, 10 male and 5 female, aged 21 to 35 years. Each of the doses was administered at intervals of 7 or more days. Ten volunteers each received 0.5 and 1 g of cefamandole intramuscularly (i.m.). Serum was collected before injection of cefamandole and then at 0.5, 1, 2, 4, 6, 8, and 24 h. Urine was collected during the first 8 h and then from 8 to 24 h. Cefamandole was administered intravenously (i.v.) by diluting 500 mg in 5% dextrose and water and injecting the drug over a 15-min period. Serum specimens we-re collected before injection and then at 45, 75, 135, and 255 min after the beginning of the infusion. A 1-g dose was administered in the same manner, but serum specimens were collected at 15, 30, 45, 60, 75, 90, 120, and 240 min after the beginning of the infusion. Urine specimens were collected from 0 to 8 and 8 to 24 h. All volunteers were in the fasting state, had voided before injection of cefamandole, and remained sedentary during the study period. All volunteers had normal hemograms and normal values for blood urea nitrogen, serum creatinine, bilirubin, glutamic oxaloacetic acid transaminase, glutamic pyruvic acid transaminase, alkaline phosphatase, uric acid, albumin, and globulin before and after the study.Blood specimens were centrifuged after clotting at room temperature for 1 h; sera and filtered urine specimens were frozen and stored at -70 C. A modifield agar plate assay with paper disks (6.35 mm, Schleicher & Schuell Co.), with Bacillus subtilis spore suspension (Difco), was used to determine cefamandole concentrations (1, 4). All tests were run at least three times.The regression lines of the logs of serum concentratio...